Selaglob 400 Mg Tablet 10

SELAGLOB 400 MG TABLET 10 is intended for adults with chronic kidney disease who are receiving dialysis and need treatment to lower raised phosphate levels and reduce related health complications.

Uses of SELAGLOB 400 MG TABLET 10 are:

• Hyperphosphataemia in Kidney Disease: Helps lower high phosphate levels in adults with chronic kidney disease who are receiving dialysis.
• Bone Health Support: Helps reduce phosphate build-up associated with weakening of the bones.
• Cardiovascular Protection: Helps manage raised phosphate levels that may be linked with heart and blood vessel problems.

Follow these instructions while taking SELAGLOB 400 MG TABLET 10:

• Swallow the tablet whole with a glass of water during meals.
• Do not crush, chew, split, or break the tablet.
• Check the expiry date of the medicine before taking it.
• Always consult your doctor before changing your dose or stopping the medicine.

SELAGLOB 400 MG TABLET 10 is taken orally.

SELAGLOB 400 MG TABLET 10 contains sevelamer (400 mg) that functions in the body as follows:

• Phosphate binding: Sevelamer binds dietary phosphate in the gastrointestinal tract, preventing its absorption into the bloodstream. This action subsequently reduces blood phosphate levels.
• Cholesterol reduction: Apart from controlling phosphate levels, sevelamer also reduces serum LDL cholesterol and total cholesterol levels.

• Store SELAGLOB 400 MG TABLET 10 in a cool, dry place. The ideal storage temperature is room temperature below 30°C.
• Protect the tablet from heat and moisture.
• Keep it out of reach and sight of children.
• Always use the tablet before its expiry date.

• Monitor your dietary phosphate intake. As SELAGLOB 400 MG TABLET 10 manages high blood phosphate levels, reducing your intake of phosphate-rich foods such as dairy products, whole grains, and organ meats can assist in managing your condition.
• Maintain a heart-healthy lifestyle. Regular exercise and a diet low in saturated fats can help reduce your risk of heart disease and stroke, which are often associated with chronic kidney disease.